Inventor · disambiguated record
Mohan Srinivasan
Also filed as: SRINIVASAN MOHAN
67 granted patents·35 pending applications·6,452 citations·filing 2003–2024
99Inventor score
Top patents by PatentIndex Score
102 records- 0199US10441655B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2016·Granted Oct 15, 2019·25 cites·22 claims
- 0299US9580507B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2016·Granted Feb 28, 2017·129 cites·30 claims
- 0399US9505839B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·123 cites·16 claims
- 0499US9492539B2Monoclonal antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·119 cites·65 claims
- 0599US9492540B2Methods for treating cancer using anti-PD-1 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·139 cites·79 claims
- 0699US9387247B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Jul 12, 2016·124 cites·45 claims
- 0799US9358289B2Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Jun 7, 2016·137 cites·49 claims
- 0899US9273135B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Mar 1, 2016·109 cites·30 claims
- 0999US9102725B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2013·Granted Aug 11, 2015·120 cites·31 claims
- 1099US8383796B2Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2011·Granted Feb 26, 2013·355 cites·31 claims
- 1199US8008449B2Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeuticsMEDAREX INC·Filed 2006·Granted Aug 30, 2011·2.2k cites·23 claims
- 1299US7943743B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2006·Granted May 17, 2011·1.5k cites·26 claims
- 1398US10377824B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 13, 2019·19 cites·30 claims
- 1498US10266591B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 23, 2019·20 cites·37 claims
- 1598US9580505B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Feb 28, 2017·37 cites·41 claims
- 1698US9228016B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 5, 2016·85 cites·19 claims
- 1798US9084776B2Methods for treating cancer using anti-PD-1 antibodiesMEDAREX LLC·Filed 2014·Granted Jul 21, 2015·203 cites·9 claims
- 1898US8779105B2Monoclonal antibodies to programmed death 1 (PD-1)KORMAN ALAN J·Filed 2011·Granted Jul 15, 2014·479 cites·30 claims
- 1997US10501550B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·9 cites·58 claims
- 2097US10465010B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 5, 2019·9 cites·15 claims
- 2197US10189902B2Antibodies to TIGITBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 29, 2019·27 cites·8 claims
- 2297US9745379B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 29, 2017·11 cites·58 claims
- 2397US9605080B2Antibodies against CD73BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 28, 2017·31 cites·30 claims
- 2497US7662381B2Interferon alpha receptor 1 antibodies and their usesMEDAREX INC·Filed 2005·Granted Feb 16, 2010·47 cites·20 claims
- 2596US10100129B2Antibodies against CD73 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 16, 2018·24 cites·35 claims
- 2696US7456264B2Human monoclonal antibodies against Bacillus anthracis protective antigenMEDAREX INC·Filed 2004·Granted Nov 25, 2008·88 cites·32 claims
- 2796US7217796B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2003·Granted May 15, 2007·105 cites·81 claims
- 2895US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 2994US11345752B2Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 31, 2022·4 cites·36 claims
- 3094US11084881B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 10, 2021·3 cites·19 claims
- 3193US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 3293US8945553B2Bispecific antibodies to IL-23 and IL-17A/FBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Feb 3, 2015·16 cites·12 claims
- 3392US10690674B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·5 cites·27 claims
- 3492US8258266B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2009·Granted Sep 4, 2012·28 cites·17 claims
- 3591US10653791B2Antibodies comprising modified heavy constant regionsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 19, 2020·10 cites·6 claims
- 3691US2025136684A1Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 3790US12215163B2CD25 antibodiesIBIO INC·Filed 2021·Granted Feb 4, 2025·3 cites·24 claims
- 3890US10167343B2Antibodies against CD73BRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·3 cites·34 claims
- 3990US8460668B2Interferon alpha receptor I antibodies and their useCARDARELLI JOSEPHINE M·Filed 2010·Granted Jun 11, 2013·11 cites·18 claims
- 4090US8247537B2Human monoclonal antibodies to BTLA and methods of useKORMAN ALAN·Filed 2007·Granted Aug 21, 2012·20 cites·18 claims
- 4189US8580259B2Human monoclonal antibodies to BTLA and methods of useKORMAN ALAN·Filed 2012·Granted Nov 12, 2013·15 cites·43 claims
- 4288US2024158524A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4387US11072664B2Interferon receptor 1 antibodies and their usesSQUIBB & SONS LLC·Filed 2019·Granted Jul 27, 2021·3 cites·20 claims
- 4487US7851181B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2007·Granted Dec 14, 2010·7 cites·45 claims
- 4587US7847068B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2006·Granted Dec 7, 2010·7 cites·99 claims
- 4686US7667021B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2006·Granted Feb 23, 2010·6 cites·46 claims
- 4786US2023272079A1Monoclonal Antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2023·Application pending·0 cites
- 4884US11408889B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 4984US8496931B2Monoclonal antibodies against stromal derived factor-1 (SDF-1)POGUE SARAH L·Filed 2007·Granted Jul 30, 2013·13 cites·38 claims
- 5083US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mohan Srinivasan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →